Alison S. Long - Dec 15, 2021 Form 4 Insider Report for Kaleido Biosciences, Inc. (KLDO)

Role
Chief Medical Officer
Signature
/s/ Alison S. Long
Stock symbol
KLDO
Transactions as of
Dec 15, 2021
Transactions value $
$0
Form type
4
Date filed
12/16/2021, 04:18 PM
Next filing
Jan 18, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KLDO Stock Option (Right to Buy) Award $0 +300K $0.00 300K Dec 15, 2021 Common Stock 300K $3.08 Direct F1
transaction KLDO Restricted Stock Units Award $0 +24.4K $0.00 24.4K Dec 15, 2021 Common Stock 24.4K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest on December 15, 2022, with the remainder vesting in 12 equal quarterly installments thereafter.
F2 Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
F3 The restricted stock units shall vest 100% on December 15, 2023.